Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Velcade Patent Ruling Puts More Pressure On Ixazomib Candidate

This article was originally published in The Pink Sheet Daily

Executive Summary

District court finds formulation patent covering Takeda’s top drug is obvious in light of prior art, opening product up to generic competition in 2017.


Related Content

Takeda’s Global Ambitions Focus On Crohn’s, Cancer – And Churn


Related Companies